Results 91 to 100 of about 36,686 (259)

Taste Dysfunction and Bell's Palsy: A Scoping Review

open access: yesThe Laryngoscope, EarlyView.
Taste dysfunction is a well‐recognized but inconsistently reported symptom in Bell's palsy. This scoping review found that taste dysfunction is prevalent in these patients, often precedes facial weakness, and commonly improves within 6 months. Standardized, longitudinal studies employing validated psychophysical measures are needed to clarify the ...
Sherina R. Thomas   +2 more
wiley   +1 more source

UPFP-SG: A New Benchmark for Unilateral Peripheral Facial Paralysis Severity Grading

open access: yesIEEE Transactions on Neural Systems and Rehabilitation Engineering
Unilateral facial palsy, a common type of facial paralysis, profoundly impacts individuals’ daily functionality and quality of life. The current clinical diagnosis of facial paralysis primarily relies on the subjective judgment of doctors, and the
Wei Gan   +8 more
doaj   +1 more source

The Hidden Burden of Hemifacial Spasm: A Systematic Review of Non‐Motor Symptoms

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Hemifacial spasm (HFS) is a chronic neurological disorder characterized by involuntary contractions of facial muscles. Traditionally regarded as a motor condition, HFS encompasses a spectrum of non‐motor symptoms that are often overlooked but significantly affect patients’ quality of life.
Miriam Carvalho Soares   +2 more
wiley   +1 more source

Facial Paralysis [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1920
openaire   +2 more sources

Real‐World Patterns of Botulinum Toxin Treatment in Hyperkinetic Movement Disorders: A 9‐Year Nationwide Analysis in France

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Hyperkinetic movement disorders, including dystonia, tremor, and myoclonus, are disabling conditions often managed with botulinum toxin type A (BoNT‐A). Real‐world evidence on treatment patterns remains limited. Objective This nationwide, population‐based study aimed to evaluate trends in BoNT‐A use in France between 2015 and 2023 ...
Marion Simonetta‐Moreau   +3 more
wiley   +1 more source

Recurrent Idiopathic Facial Paralysis: A Case Report

open access: yesThe Turkish Journal of Gastroenterology, 2010
Idiopathic facial paralysis is the mononeuropathy Multiple recurrences of idiopathic facial paralysis in a patient may be the sign or sympton of a serious illness.
Hale Hekim Baloğlu   +3 more
doaj  

Living with the Unknown: Intolerance of Uncertainty in Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinson's disease (PD) is marked by pervasive uncertainty due to fluctuating motor and non‐motor symptoms, variable treatment response, and an unpredictable clinical course. Intolerance of uncertainty (IU), a tendency to perceive ambiguity as threatening and respond with worry, avoidance, or decisional paralysis, may be ...
Bradley McDaniels   +3 more
wiley   +1 more source

Review of Congenital Myasthenic Syndrome Caused by Pathogenic Variants in GFPT1

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Glutamine:fructose‐6‐phosphate transaminase 1 (GFPT1) catalyzes the first and rate‐limiting step of the hexosamine biosynthetic pathway (HBP) to generate UDP‐GlcNAc. GFPT1 exon 9 is specifically spliced in in striated muscles, which makes a long isoform of GFPT1 (GFPT1‐L).
Kinji Ohno   +5 more
wiley   +1 more source

AGRN‐, LRP4‐, MUSK‐Related CMS: Clinical, Neurophysiological, Morphological, Genetic and Pathological Mechanisms

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Congenital myasthenic syndromes (CMS) are inherited disorders caused by mutations in genes encoding proteins essential for neuromuscular junction (NMJ) function. Pathogenic variants have been identified in more than 35 genes, underscoring the complexity of synaptic biology and the wide range of mechanisms that can compromise neuromuscular ...
Rocio‐Nur Villar‐Quiles   +5 more
wiley   +1 more source

Myasthenia Gravis and Thymoma

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Thymoma is the most common tumor of the anterior mediastinum. Approximately 20%–30% of patients with a thymoma develop myasthenia gravis (MG), and an additional one third may possess positive acetylcholine receptor (AChR) antibodies without MG.
Benjamin Claytor   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy